These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4255014)

  • 1. Inhibitors of fibrinolysis in platelets in polycythaemia vera and thrombocytosis.
    Kwaan HC; Suwanwela N
    Br J Haematol; 1971 Sep; 21(3):313-22. PubMed ID: 4255014
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on an inhibitor of plasminogen activators in human platelets.
    Murray J; Crawford GP; Ogston D; Douglas AS
    Br J Haematol; 1974 Apr; 26(4):661-8. PubMed ID: 4276857
    [No Abstract]   [Full Text] [Related]  

  • 3. A hitherto undescribed defect of platelet coagulant activity in polycythaemia vera and essential thrombocythaemia.
    Semeraro N; Cortellazzo S; Colucci M; Barbui T
    Thromb Res; 1979; 16(5-6):795-802. PubMed ID: 524321
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative activities of amino acid and polypeptide inhibitors on natural and synthetic substrates.
    Skoza L; Tse AO; Semar M; Johnson AJ
    Ann N Y Acad Sci; 1968 Jun; 146(2):659-72. PubMed ID: 4239440
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasminogen-plasmin system. VII. Potentiation of antifibrinolytic action of a synthetic inhibitor, tranexamic acid, by alpha 2-macroglobulin antiplasmin.
    Abiko Y; Iwamoto M
    Biochim Biophys Acta; 1970 Sep; 214(3):411-8. PubMed ID: 4251764
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the mechanism of action of synthetic antifibrinolytics. A comparison with the action of derivatives of benzamidine on the fibrinolytic process.
    Landmann H
    Thromb Diath Haemorrh; 1973 May; 29(2):253-75. PubMed ID: 4271586
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombocytosis.
    Selroos O
    Acta Med Scand; 1973 May; 193(5):431-6. PubMed ID: 4717324
    [No Abstract]   [Full Text] [Related]  

  • 8. [Blood coagulation and fibrinolysis in chronic myeloproliferative syndromes].
    Takahashi K; Shibata A
    Rinsho Ketsueki; 1980 May; 21(5):577-86. PubMed ID: 6997548
    [No Abstract]   [Full Text] [Related]  

  • 9. Spontaneous platelet aggregation in myeloproliferative disorders. A preliminary study.
    Barbui T; Battista R; Dini E
    Acta Haematol; 1973; 50(1):25-9. PubMed ID: 4200801
    [No Abstract]   [Full Text] [Related]  

  • 10. THE BEHAVIOUR AND SURVIVAL OF PLATELETS IN POLYCYTHAEMIA AND THROMBOCYTHAEMIA.
    LANDER H; DAVEY MG
    Australas Ann Med; 1964 Aug; 13():207-16. PubMed ID: 14194838
    [No Abstract]   [Full Text] [Related]  

  • 11. Characteristic changes in platelet-large cell ratio, lactate dehydrogenase and C-reactive protein in thrombocytosis-related diseases.
    Kabutomori O; Kanakura Y; Iwatani Y
    Acta Haematol; 2007; 118(2):84-7. PubMed ID: 17622783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinolytic potential in polycythemia rubra vera.
    Bick RL
    Beitr Pathol; 1974 Apr; 151(4):401-4. PubMed ID: 4276091
    [No Abstract]   [Full Text] [Related]  

  • 13. The fibrinolytic system and proteins C and S in treated polycythaemia rubra vera.
    Wieczorek I; MacGregor IR; Prescott RJ; Ludlam CA
    Blood Coagul Fibrinolysis; 1992 Dec; 3(6):823-6. PubMed ID: 1489903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet function in patients with high platelet counts.
    Ginsburg AD
    Ann Intern Med; 1975 Apr; 82(4):506-11. PubMed ID: 1054537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Temperature-dependent spontaneous platelet aggregation in polycythemia vera and primary thrombocythemia: a diagnostic criterion].
    Fröhli P; Streuli R; Rhyner K
    Klin Wochenschr; 1984 May; 62(9):412-6. PubMed ID: 6727282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolysis.
    Fearnley GR
    Adv Drug Res; 1973; 7():107-63. PubMed ID: 4280240
    [No Abstract]   [Full Text] [Related]  

  • 17. [Physiology of hemostasis. II. Fibrinolysis].
    Sultan Y; Caen J; Allain JP; Meyer D
    Pathol Biol (Paris); 1969 May; 17(9):529-34. PubMed ID: 4240805
    [No Abstract]   [Full Text] [Related]  

  • 18. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
    Veremeenko KN; Kizim AI
    Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Natural inhibitors of fibrinolysis and their physiological importance].
    Pastorova VE
    Usp Fiziol Nauk; 1974; 5(4):80-95. PubMed ID: 4279526
    [No Abstract]   [Full Text] [Related]  

  • 20. Significance of abnormal LDH isoenzyme pattern in human platelets.
    Knudsen FU
    Acta Haematol; 1971; 45(2):99-105. PubMed ID: 4996571
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.